Comparing the real-world and clinical trial bleeding rates associated with oral anticoagulation treatment for atrial fibrillation

被引：0
|
作者：
Gue, Y. X. [1 ]
Bloomfield, D. [2 ]
Freedholm, D. [2 ]
Lip, G. [1 ]
机构：
[1] Univ Liverpool, Sch Med, Liverpool, England
[2] Anthos Therapeut, Cambridge, MA USA
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Stroke risk based on classification of atrial fibrillation: real-world vs clinical trial
    Ding, W. Y.
    Rivera-Caravaca, J. M.
    Marin, F.
    Roldan, V.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2021, 42 : 470 - 470
  • [22] CLINICAL AUDIT OF STROKE ADMISSIONS ASSOCIATED WITH ATRIAL FIBRILLATION AND ANTICOAGULATION RATES
    Khan, Zainab
    Gopinath, Sumana
    Levy, Stanley
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (06): : E29 - E30
  • [23] Atrial Fibrillation and Mitral Regurgitation: Clinical Performance of Direct Oral Anticoagulants in a Real-World Setting
    Melillo, Enrico
    Rago, Anna
    Proietti, Riccardo
    Attena, Emilio
    Carrella, Maddalena
    Golino, Paolo
    D'Onofrio, Antonio
    Nigro, Gerardo
    Russo, Vincenzo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (06) : 564 - 569
  • [24] Rates of major bleeding with rivaroxaban in real-world studies of nonvalvular atrial fibrillation patients: a meta-analysis
    Weeda, Erin R.
    White, C. Michael
    Peacock, W. Frank
    Coleman, Craig I.
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (06) : 1117 - 1120
  • [25] Bleeding Tolerance Among Patients With Atrial Fibrillation on Oral Anticoagulation
    Rusin, Gabriela
    Konieczynska, Malgorzata
    Bijak, Piotr
    Desteghe, Lien
    Heidbuchel, Hein
    Malinowski, Krzysztof Piotr
    Undas, Anetta
    CANADIAN JOURNAL OF CARDIOLOGY, 2020, 36 (04) : 500 - 508
  • [26] Bleeding risk during oral anticoagulation therapy for atrial fibrillation
    Gallego, Pilar
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    EUROPACE, 2013, 15 (06): : 773 - 774
  • [27] Rates of thromboembolism and bleeding with antithrombotic treatment in patients with atrial fibrillation: a "real world" nationwide cohort study
    Olesen, J. B.
    Lip, G. Y. H.
    Lane, D. A.
    Ahlehoff, O.
    Lindhardsen, J.
    Olsen, A. M. S.
    Hansen, P. R.
    Gislason, G. H.
    Torp-Pedersen, C.
    EUROPEAN HEART JOURNAL, 2011, 32 : 465 - 465
  • [28] Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation: A Real-World Setting
    Fontaine, Gabriel V.
    Mathews, Katy D.
    Woller, Scott C.
    Stevens, Scott M.
    Lloyd, James F.
    Evans, R. Scott
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (07) : 665 - 672
  • [29] Real-world complexity of atrial fibrillation treatment with oral anticoagulants: design and interpretation of pharmacoepidemiological studies
    Meid, Andreas D.
    Maechler, Sarah
    Haefeli, Walter E.
    Mikus, Gerd
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 83 (10) : 2321 - 2324
  • [30] Do clinical trial cohorts reflect the complexities of real-world patients with chronic atrial fibrillation?
    Ball, J.
    Carrington, M. J.
    Stewart, S.
    EUROPEAN HEART JOURNAL, 2012, 33 : 955 - 955
12345